DDAVP Side Effects

7027039-4 | Blood Sodium Decreased, Headache, Polyuria
on Sep 14, 2010 Female patient from GREECE , 57 years of age, weighting 130.1 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: blood sodium decreased, headache (What is headache?), polyuria. Ddavp dosage: . During the same period patient was treated with MINIRIN (View Minirin Review and Minirin Label ).

6960208-8 | Coronary Artery Occlusion, Myocardial Infarction
Patient was taking Ddavp (View Usage). Patient had the following side effects: coronary artery occlusion, myocardial infarction on Aug 24, 2010 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 138.0 lb, . Ddavp dosage: Last Dose @9:20 Am Dose:0.4 Microgram(s)/millilitre. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6936287-0 | Encephalitis Herpes, Erythema, Gastrointestinal Hypomotility, Haemorrhage, Hypernatraemia, Ill-defined Disorder, Nervous System Disorder, Pollakiuria
Adverse event was reported on Aug 13, 2010 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: UNITED STATES , weighting 110.0 lb, After Ddavp was administered, patient had the following side effects: encephalitis herpes, erythema, gastrointestinal hypomotility, haemorrhage, hypernatraemia, ill-defined disorder, nervous system disorder, pollakiuria. Patient was hospitalized.

6934091-0 | Encephalitis Herpes, Erythema, Gastrointestinal Hypomotility, Haemorrhage, Hypernatraemia, Ill-defined Disorder, Nervous System Disorder, Pollakiuria
on Aug 08, 2010 Female patient from UNITED STATES , weighting 110.0 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: encephalitis herpes, erythema, gastrointestinal hypomotility, haemorrhage, hypernatraemia, ill-defined disorder, nervous system disorder, pollakiuria. Ddavp dosage: . Patient was hospitalized.


6923282-0 | Coronary Artery Occlusion, Myocardial Infarction
on Aug 03, 2010 Female patient from UNITED STATES , 63 years of age, weighting 138.0 lb, was treated with Ddavp (View Usage). Patient had the following side effects: coronary artery occlusion, myocardial infarction. Ddavp dosage: Last Dose @9:20 Am. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

6923260-1 | Amnesia, Chills, Convulsion, Disorientation, Disturbance In Attention, Eye Infection, Flushing, Gastritis, Hordeolum
Patient was taking Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: amnesia, chills, convulsion, disorientation, disturbance in attention, eye infection (What is eye infection?), flushing, gastritis, hordeolum on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , 29 years of age, . Ddavp dosage: . During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ZOMIG (Qid /prn Up To A Max Of 4 Doses/day) (View Zomig Review and Zomig Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6847861-4 | Amnesia, Chills, Convulsion, Disorientation, Disturbance In Attention, Eye Infection, Flushing, Gastritis, Hypokalaemia
Adverse event was reported on Jul 07, 2010 by a Male patient taking Ddavp (View Usage) (Dosage: ) . Location: UNITED STATES , 29 years of age, Patient experienced the following unwanted or unexpected effects: amnesia, chills, convulsion, disorientation, disturbance in attention, eye infection (What is eye infection?), flushing, gastritis, hypokalaemia. During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ZOMIG (View Zomig Review and Zomig Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6785536-0 | Amnesia, Chills, Convulsion, Disorientation, Disturbance In Attention, Eye Infection, Flushing, Gastritis, Hypokalaemia
on Jun 11, 2010 Male patient from UNITED STATES , 29 years of age, was treated with Ddavp (View Usage). Patient had the following side effects: amnesia, chills, convulsion, disorientation, disturbance in attention, eye infection (What is eye infection?), flushing, gastritis, hypokalaemia. Ddavp dosage: . During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ZOMIG (View Zomig Review and Zomig Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6763003-8 | Diabetes Insipidus, Hypopituitarism
on Jun 08, 2010 Female patient from UNITED STATES , weighting 138.2 lb, was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), hypopituitarism. Ddavp dosage: 15 Units Am 25 Units Pm Sq.

6762300-X | Amnesia, Chills, Convulsion, Disorientation, Disturbance In Attention, Eye Infection, Flushing, Gastritis, Hypokalaemia
Patient was taking Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, chills, convulsion, disorientation, disturbance in attention, eye infection (What is eye infection?), flushing, gastritis, hypokalaemia on Jun 02, 2010 from UNITED STATES Additional patient health information: Male patient , 29 years of age, . Ddavp dosage: . During the same period patient was treated with CLARITIN (View Claritin Review and Claritin Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ZOMIG (View Zomig Review and Zomig Label ), DITROPAN (View Ditropan Review and Ditropan Label ). Patient was hospitalized.

6696741-6 | Blood Sodium Decreased, Brain Oedema, Lethargy
Adverse event was reported on Apr 14, 2010 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with bladder disorder, multiple sclerosis (What is multiple sclerosis?), toothache and. Location: UNITED STATES , 60 years of age, weighting 141.1 lb, Patient had the following side effects: blood sodium decreased, brain oedema, lethargy. During the same period patient was treated with INTERFERON BETA (View Interferon Beta Review and Interferon Beta Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), NAPROXEN SODIUM (View Naproxen Sodium Review and Naproxen Sodium Label ), ADVIL (View Advil Review and Advil Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6619888-9 | Anuria, Convulsion, Overdose
on Feb 03, 2010 Female patient from UNITED STATES , weighting 141.1 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: anuria, convulsion, overdose. Ddavp dosage: ().

6618899-7 | Convulsion, Dysuria, Overdose
on Feb 03, 2010 Female patient from UNITED STATES , weighting 141.1 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, dysuria, overdose. Ddavp dosage: Can't Find The Correct Dosage (this Is The Problem); It's Not A Specific Bottle..

6583165-5 | Convulsion, Dysuria, Overdose
Patient was taking Ddavp (View Usage). Patient had the following side effects: convulsion, dysuria, overdose on Feb 03, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Ddavp dosage: Can't Find The Correct Dosage (this Is The Problem); It's Not A Specific Bottle..

6466672-5 | Atrial Fibrillation, Pollakiuria, Thirst
Adverse event was reported on Dec 01, 2009 by a Female patient taking Ddavp (View Usage) (Dosage: 1/2 Of 0.1 Mg Daily/as Needed 1 Daily Po) was diagnosed with diabetes insipidus (What is diabetes insipidus?), atrial fibrillation (What is atrial fibrillation?) and. Location: UNITED STATES , 83 years of age, weighting 100.0 lb, After Ddavp was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), pollakiuria, thirst. During the same period patient was treated with WARFARIN SODIUM (1 Mg 1 Daily Po) (View Warfarin Sodium Review and Warfarin Sodium Label ).

6407743-9 | Hospitalisation
on Oct 12, 2009 Male patient from UNITED STATES , weighting 250.0 lb, was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: hospitalisation. Ddavp dosage: Dose: Unk. Patient was hospitalized.

6395085-X | Hospitalisation
on Sep 28, 2009 Male patient from UNITED STATES , weighting 250.0 lb, was treated with Ddavp (View Usage). Patient had the following side effects: hospitalisation. Ddavp dosage: Dose: Unk. Patient was hospitalized.

6269167-7 | Hypernatraemia, Urine Analysis Abnormal
Patient was taking Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: hypernatraemia, urine analysis abnormal on Jul 08, 2009 from UNITED STATES Additional patient health information: Male patient , 14 years of age, . Ddavp dosage: Dose: 0.8 Morning And 0.7 Evening.

6122613-1 | Cognitive Disorder, Condition Aggravated, Depression
Adverse event was reported on Mar 09, 2009 by a Male patient taking Ddavp (View Usage) (Dosage: Dose: 3 Tablets Decreased To One Sixteenth Of A 0.1 Mg Tablet) . Location: UNITED STATES , weighting 155.0 lb, Patient experienced the following unwanted or unexpected effects: cognitive disorder, condition aggravated, depression (What is depression?). During the same period patient was treated with WELLBUTRIN (Dose: Unk) (View Wellbutrin Review and Wellbutrin Label ), ANTIDEPRESSANTS (Dose: Unk) (View Antidepressants Review and Antidepressants Label ), DESYREL (View Desyrel Review and Desyrel Label ).

6120379-2 | Dehydration, Hypernatraemia
on Mar 13, 2009 Male patient from UNITED STATES , weighting 158.1 lb, was treated with Ddavp (View Usage). Patient had the following side effects: dehydration, hypernatraemia. Ddavp dosage: 0.2 Mg Tablet. Patient was hospitalized.

6092678-4 | Cognitive Disorder, Depression
on Feb 16, 2009 Male patient from UNITED STATES , 27 years of age, was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: cognitive disorder, depression (What is depression?). Ddavp dosage: Dose: 3 Tablets Decreased To One Sixteenth Of A 0.1 Mg Tablet. During the same period patient was treated with WELLBUTRIN (Dose: Unk) (View Wellbutrin Review and Wellbutrin Label ).

6082374-1 | Type 2 Diabetes Mellitus
Patient was taking Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: type 2 diabetes mellitus on Feb 06, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 210.0 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?), lipids increased and. Ddavp dosage: Dose: 1 Spray Twice A Day, ^20 Mcg^. During the same period patient was treated with ZOCOR (Dose: Unk) (View Zocor Review and Zocor Label ), ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ), CRESTOR (Dose: Unk) (View Crestor Review and Crestor Label ).

6075875-3 | Depression, Intentional Self-injury, Restlessness
Adverse event was reported on Jan 28, 2009 by a Female patient taking Ddavp (View Usage) (Dosage: 1000 Mcg/1400 Mcg, Po) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: UNITED KINGDOM , 17 years of age, Patient had the following side effects: depression (What is depression?), intentional self-injury, restlessness. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6074221-9 | Intentional Self-injury
on Feb 06, 2009 Female patient from UNITED KINGDOM , 17 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: intentional self-injury. Ddavp dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6064850-0 | Myocardial Infarction, Type 2 Diabetes Mellitus
on Jan 22, 2009 Male patient from UNITED STATES , weighting 210.0 lb, was diagnosed with diabetes insipidus (What is diabetes insipidus?), lipids increased and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction, type 2 diabetes mellitus. Ddavp dosage: Dose: 1 Spray. During the same period patient was treated with ZOCOR (Dose: Unk) (View Zocor Review and Zocor Label ), ASPIRIN (Dose: Unk) (View Aspirin Review and Aspirin Label ), CRESTOR (Dose: Unk) (View Crestor Review and Crestor Label ).

5948377-X | Convulsion, Headache, Vaginal Haemorrhage
Patient was taking Ddavp (View Usage). Patient had the following side effects: convulsion, headache (What is headache?), vaginal haemorrhage on Nov 03, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 50.00 lb, . Ddavp dosage: . During the same period patient was treated with CONCERTA (View Concerta Review and Concerta Label ), MULTI VITAMINS (Dose: Unk) (View Multi-vitamins Review and Multi-vitamins Label ), EPIPEN /00003901/ (Dose: Unk) (View Epipen /00003901/ Review and Epipen /00003901/ Label ). Patient was hospitalized.

5883692-X | Cognitive Disorder, Dehydration, Hyponatraemia, Memory Impairment, Thirst Decreased, Water Intoxication
Adverse event was reported on Jul 30, 2008 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Location: UNITED KINGDOM , 26 years of age, After Ddavp was administered, patient had the following side effects: cognitive disorder, dehydration, hyponatraemia, memory impairment, thirst decreased, water intoxication. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5883443-9 | Condition Aggravated, Coronary Artery Occlusion, Myocardial Infarction, Platelet Disorder
on Dec 07, 2007 Female patient from UNITED KINGDOM , 28 years of age, was diagnosed with platelet disorder and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, coronary artery occlusion, myocardial infarction, platelet disorder. Ddavp dosage: . During the same period patient was treated with TRANEXAMIC ACID ()(TRANEXAMIC ACID) (3 G Po) (View Tranexamic Acid ()(tranexamic Acid) Review and Tranexamic Acid ()(tranexamic Acid) Label ). Patient was hospitalized.

5883441-5 | Condition Aggravated, Coronary Artery Occlusion, Haemorrhage, Myocardial Infarction
on Aug 22, 2008 Female patient from UNITED KINGDOM , 28 years of age, was diagnosed with platelet disorder and was treated with Ddavp (View Usage). Patient had the following side effects: condition aggravated, coronary artery occlusion, haemorrhage, myocardial infarction. Ddavp dosage: . During the same period patient was treated with PROGESTERONE (View Progesterone Review and Progesterone Label ), TRANEXAMIC ACID ( ) (TRANEXAMIC ACID) (3 G, Po) (View Tranexamic Acid ( ) (tranexamic Acid) Review and Tranexamic Acid ( ) (tranexamic Acid) Label ). Patient was hospitalized.

5872048-1 | Myocardial Infarction
Patient was taking Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: myocardial infarction on Sep 01, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 28 years of age, was diagnosed with contraception and. Ddavp dosage: . During the same period patient was treated with TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ). Patient was hospitalized.

5859135-9 | Acute Myocardial Infarction, Coronary Artery Occlusion, Haemorrhage
Adverse event was reported on Aug 11, 2008 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with platelet disorder and. Location: UNITED KINGDOM , 28 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, coronary artery occlusion, haemorrhage. During the same period patient was treated with TRANEXAMIC ACID () (TRANEXAMIC ACID) (3 G Po) (View Tranexamic Acid () (tranexamic Acid) Review and Tranexamic Acid () (tranexamic Acid) Label ). Patient was hospitalized.

5849764-0 | Intentional Self-injury, Restlessness
on Aug 04, 2008 Female patient from UNITED KINGDOM , 17 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). Patient had the following side effects: intentional self-injury, restlessness. Ddavp dosage: 1000 Mcg, Po. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5822574-6 | Depression, Intentional Self-injury, Restlessness
on Jul 07, 2008 Female patient from UNITED KINGDOM , 17 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: depression (What is depression?), intentional self-injury, restlessness. Ddavp dosage: 1000 Mcg Po. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5821679-3 | Depression, Intentional Self-injury, Restlessness
Patient was taking Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), intentional self-injury, restlessness on Jul 17, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Ddavp dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

5809788-6 | Colitis Ulcerative, Haemorrhage
Adverse event was reported on Jul 07, 2008 by a Male patient taking Ddavp (View Usage) (Dosage: Dose: One Spray In Each Nostril) . Location: UNITED STATES , child 7 years of age, Patient had the following side effects: colitis ulcerative, haemorrhage. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Dose: Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5755775-6 | Pulmonary Oedema
on May 22, 2008 Female patient from UNITED STATES , 18 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: pulmonary oedema. Ddavp dosage: . Patient was hospitalized.

5746681-1 | Chills, Off Label Use, Overdose, Pallor, Poisoning
on May 19, 2008 Male patient from UNITED STATES , weighting 164.3 lb, was diagnosed with bone pain and was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: chills, off label use, overdose, pallor, poisoning (What is poisoning?). Ddavp dosage: Dose: 1 Puff Am + Pm. During the same period patient was treated with ANALGESICS (Dose: Unk) (View Analgesics Review and Analgesics Label ), ATARAX (View Atarax Review and Atarax Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), FLURBIPROFEN (Dose: Unk) (View Flurbiprofen Review and Flurbiprofen Label ). Patient was hospitalized.

5690436-3 | Chills, Off Label Use, Overdose, Pallor, Poisoning
Patient was taking Ddavp (View Usage). Patient had the following side effects: chills, off label use, overdose, pallor, poisoning (What is poisoning?) on Mar 20, 2008 from UNITED STATES Additional patient health information: Male patient , 21 years of age, . Ddavp dosage: Dose: Unk. During the same period patient was treated with ANALGESICS (Dose: Unk) (View Analgesics Review and Analgesics Label ), ATARAX /00058402/ (Dose: Unk) (View Atarax /00058402/ Review and Atarax /00058402/ Label ), ANTIDEPRESSANTS (Dose: Unk) (View Antidepressants Review and Antidepressants Label ). Patient was hospitalized.

5630545-8 | Hyponatraemia
Adverse event was reported on Feb 07, 2008 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with nasal congestion and. Location: UNITED STATES , 47 years of age, After Ddavp was administered, patient had the following side effects: hyponatraemia. During the same period patient was treated with FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ). Patient was hospitalized.

5568423-5 | Myocardial Infarction
on Dec 14, 2007 Female patient from UNITED KINGDOM , 28 years of age, was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Ddavp dosage: . During the same period patient was treated with TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ). Patient was hospitalized.

5444552-1 | Convulsion, Hyponatraemia, Overdose
on Aug 30, 2007 Female patient from UNITED KINGDOM , weighting 25.04 lb, was diagnosed with hypopituitarism and was treated with Ddavp (View Usage). Patient had the following side effects: convulsion, hyponatraemia, overdose. Ddavp dosage: . During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), HUMAN GROWTH HORMONE, RECOMBINANT (Dose: Unk) (View Human Growth Hormone, Recombinant Review and Human Growth Hormone, Recombinant Label ).

5351632-8 | Chills, Hypotension, Nausea
Patient was taking Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: chills, hypotension, nausea (What is nausea?) on Dec 08, 2006 from UNITED STATES Additional patient health information: Male patient , 17 years of age, weighting 130.1 lb, was diagnosed with coagulopathy, prophylaxis and. Ddavp dosage: 18 Ug Once Iv. During the same period patient was treated with AMICAR (50 Mg/kg Qid) (View Amicar Review and Amicar Label ).

5333354-2 | Blood Sodium Increased, Fluid Retention, Migraine, Oliguria, Vital Capacity Decreased
Adverse event was reported on May 16, 2007 by a Female patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with diabetes insipidus (What is diabetes insipidus?), growth hormone deficiency and. Location: UNITED STATES , weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: blood sodium increased, fluid retention, migraine (What is migraine?), oliguria, vital capacity decreased. During the same period patient was treated with DILANTIN (Dose: Unk) (View Dilantin Review and Dilantin Label ), GROWTH HORMONE (NOS) (Dose: Unk) (View Growth Hormone (nos) Review and Growth Hormone (nos) Label ). Patient was hospitalized.

5270951-7 | Demyelination, Hyponatraemia
on Mar 16, 2007 Female patient from UNITED KINGDOM , 39 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). Patient had the following side effects: demyelination, hyponatraemia. Ddavp dosage: . During the same period patient was treated with GROWTH HORMONE (View Growth Hormone Review and Growth Hormone Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

5262510-7 | Convulsion
on Mar 05, 2007 Female patient from UNITED STATES , weighting 63.93 lb, was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: convulsion. Ddavp dosage: .

5155292-0 | Hyponatraemia, Infusion Site Extravasation, Oedema Peripheral
Patient was taking Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia, infusion site extravasation, oedema peripheral on Nov 15, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, was diagnosed with von willebrand's disease and. Ddavp dosage: . Patient was hospitalized.

5110175-7 | Brain Oedema, Coma, Contusion, Convulsion, Fall, Head Injury, Hyponatraemia, Intracranial Pressure Increased, Status Epilepticus
Adverse event was reported on Aug 05, 2004 by a Male patient taking Ddavp (View Usage) (Dosage: ) was diagnosed with enuresis and. Location: IRELAND , 25 years of age, Patient had the following side effects: brain oedema, coma, contusion, convulsion, fall (What is fall?), head injury, hyponatraemia, intracranial pressure increased, status epilepticus.

5091280-0 | Convulsion, Grand Mal Convulsion
on Aug 24, 2006 Female patient from , 52 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and was treated with Ddavp (View Usage). After Ddavp was administered, patient had the following side effects: convulsion, grand mal convulsion. Ddavp dosage: . During the same period patient was treated with AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ), CREON (View Creon Review and Creon Label ), FEMATRIX (View Fematrix Review and Fematrix Label ), HYGROTON (View Hygroton Review and Hygroton Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

5072223-2 | Convulsion
on Aug 01, 2006 Female patient from UNITED STATES , child 11 years of age, was treated with Ddavp (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Ddavp dosage: .

5066385-0 | Cerebral Ischaemia, Dehydration, Hypovolaemic Shock, Multi-organ Failure, Thrombosis, Thrombotic Thrombocytopenic Purpura, Troponin Increased
Patient was taking Ddavp (View Usage). Patient had the following side effects: cerebral ischaemia, dehydration, hypovolaemic shock, multi-organ failure, thrombosis, thrombotic thrombocytopenic purpura, troponin increased on Jul 24, 2006 from JAMAICA Additional patient health information: Female patient , 47 years of age, was diagnosed with diabetes insipidus (What is diabetes insipidus?) and. Ddavp dosage: . Patient was hospitalized.